James Sapirstein insider trades
Open-market stock purchases and sales by James Sapirstein, Chief Executive Officer at Cocrystal Pharma, Inc, from SEC Form 4 filings since Nov 8, 2012.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 3, 2026 | COCP Cocrystal Pharma, Inc | Bought (not open market) | — |
Companies traded
- COCP Cocrystal Pharma, Inc: other filings, last Jun 3, 2026
- ZVSA ZyVersa Therapeutics, Inc: other filings, last Jul 11, 2025
- ONCO Onconetix, Inc: other filings, last Sep 26, 2024
- ENTO Entero Therapeutics, Inc: 1 sale, last Jul 2, 2024
- RENB Renovaro Inc: other filings, last Jun 25, 2024
- FWBI First Wave BioPharma, Inc: 6 sales, last Apr 1, 2024
- BWV Blue Water Biotech, Inc: other filings, last May 31, 2023
- ENOB Enochian Biosciences Inc: other filings, last Mar 6, 2023
- AZRX AzurRx BioPharma, Inc: other filings, last Jun 30, 2021
- MRZM Marizyme Inc: other filings, last Mar 5, 2021
- CTRV ContraVir Pharmaceuticals, Inc: 3 buys, last Jan 3, 2018
- RSPI RespireRx Pharmaceuticals Inc: other filings, last Dec 9, 2017